Exact Sciences Corporation (EXAS)
NASDAQ: EXAS · Real-Time Price · USD
101.20
-0.09 (-0.09%)
At close: Dec 1, 2025, 4:00 PM EST
101.11
-0.09 (-0.09%)
After-hours: Dec 1, 2025, 5:59 PM EST
Exact Sciences Employees
Exact Sciences had 7,000 employees as of December 31, 2024. The number of employees increased by 400 or 6.06% compared to the previous year.
Employees
7,000
Change (1Y)
400
Growth (1Y)
6.06%
Revenue / Employee
$440,290
Profits / Employee
-$140,940
Market Cap
19.17B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7,000 | 400 | 6.06% |
| Dec 31, 2023 | 6,600 | 200 | 3.13% |
| Dec 31, 2022 | 6,400 | -100 | -1.54% |
| Dec 31, 2021 | 6,500 | 1,500 | 30.00% |
| Dec 31, 2020 | 5,000 | 890 | 21.65% |
| Dec 31, 2019 | 4,110 | 2,133 | 107.89% |
| Dec 31, 2018 | 1,977 | 709 | 55.91% |
| Dec 31, 2017 | 1,268 | 532 | 72.28% |
| Dec 31, 2016 | 736 | 59 | 8.71% |
| Dec 31, 2015 | 677 | 441 | 186.86% |
| Dec 31, 2014 | 236 | 134 | 131.37% |
| Dec 31, 2013 | 102 | 15 | 17.24% |
| Dec 31, 2012 | 87 | 26 | 42.62% |
| Dec 31, 2011 | 61 | 26 | 74.29% |
| Dec 31, 2010 | 35 | 16 | 84.21% |
| Dec 31, 2009 | 19 | 15 | 375.00% |
| Dec 31, 2008 | 4 | -10 | -71.43% |
| Dec 31, 2007 | 14 | -8 | -36.36% |
| Dec 31, 2006 | 22 | -27 | -55.10% |
| Dec 31, 2005 | 49 | -22 | -30.99% |
| Dec 31, 2004 | 71 | -11 | -13.41% |
| Dec 31, 2003 | 82 | 7 | 9.33% |
| Dec 31, 2002 | 75 | 7 | 10.29% |
| Dec 31, 2001 | 68 | 24 | 54.55% |
| Dec 31, 2000 | 44 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
EXAS News
- 7 days ago - Exact Sciences Reinforces International Leadership in Breast Cancer with Strong Presence at 2025 San Antonio Breast Cancer Symposium - Business Wire
- 9 days ago - Exact Sciences Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Exact Sciences Corporation - EXAS - Business Wire
- 10 days ago - Why the Stock Price of This Cancer Screening Company Soared 17% Thursday - Investopedia
- 11 days ago - Exact Sciences Corporation (EXAS) M&A Call Transcript - Seeking Alpha
- 11 days ago - Biggest Stock Movers Today, Nov. 20: PACS, BBWI, & More - The Motley Fool
- 11 days ago - Why Exact Sciences Rallied Over 50% This Week - The Motley Fool
- 11 days ago - SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Exact Sciences Corporation (Nasdaq – EXAS) - GlobeNewsWire
- 11 days ago - Why Exact Sciences Stock Surged Today - The Motley Fool